P674: UPDATED RESULTS OF A PHASE 1B STUDY OF IBRUTINIB (IBR) PLUS OBINUTUZUMAB (OBIN) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). (23rd June 2022) - Ryan, C.; Brander, D.; Barr, P.; Tyekucheva, S.; Ren, Y.; Hackett, L.; McDonough, M.; Pena Del Aguila, K.; McEwan, M.; Collins, M.; Abramson, J.; Jacobsen, E.; et al.